Population PK-guided ATG Dosing in Haplo-HSCT

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To evaluate the safety and efficacy of a population pharmacokinetics (PK)-guided targeted ATG dosing strategy in haploidentical stem cell transplantation and to observe the GVHD-free, relapse-free survival (GRFS) in the cohort receiving this strategy.
Epistemonikos ID: 119afba55f9a2cec47646d6fe807114f59c26500
First added on: Aug 29, 2026